SCHEMBL9379529

SCHEMBL9379529

CCC1C(=O)N(c2ccc(Cl)c(Cl)c2)N=C1Cn1ccnc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.40
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
PGGT1B P53609 1/20 0.37
CES2 O00748 1/20 0.37
CYP11B1 P15538 6/20 0.36
CYP11B2 P19099 4/20 0.36
CYP19A1 P11511 3/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2B6 P20813 1/20 0.36
PDE4D Q08499 1/20 0.36
CYP17A1 P05093 1/20 0.36
CYP21A2 P08686 1/20 0.36
WDR5 P61964 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378758 0.90 SIGMAR1 (0.39) SIGMAR1ALOX15HSD17B10FNTAFNTB
SCHEMBL9383526 0.88 CYP19A1 (0.48) CES2CYP11B1CYP11B2CYP19A1CYP2A6
SCHEMBL9378673 0.85 CYP19A1 (0.49) CES2CYP11B1CYP11B2CYP19A1
SCHEMBL9378296 0.83 CES2 (0.55) CES2CYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL9381460 0.82 CYP19A1 (0.47) CES2CYP11B1CYP11B2CYP19A1
SCHEMBL9380139 0.80 TBXAS1 (0.41) CES2CYP11B1CYP11B2CYP19A1
SCHEMBL9382915 0.77 CYP19A1 (0.44) CES2CYP11B1CYP11B2CYP19A1CYP2A6
SCHEMBL9379264 0.76 CYP11B1 (0.40) CES2CYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL9382448 0.75 CYP19A1 (0.45) CES2CYP11B1CYP11B2CYP19A1
SCHEMBL9379532 0.74 TAAR1 (0.38) CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0269030-B1 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI CHEM IND (JP) 1994-05-04 EP disclosed
US-5089515-A Antiischemic agents; pyrazolone compounds MITSUBISHI KASEI CORPORATION (JP) 1992-02-18 US disclosed
US-4990619-A Cardiovascular disorders, antiischemic agents MITSUBISHI KASEI CORPORATION (JP) 1991-02-05 US disclosed
US-4906644-A Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1990-03-06 US disclosed
EP-0269030-A2 Lipid-peroxide formation inhibiting composition and novel compounds useful therefor MITSUBISHI KASEI CORPORATION (JP) 1988-06-01 EP disclosed